Financhill
Sell
45

SUPN Quote, Financials, Valuation and Earnings

Last price:
$31.66
Seasonality move :
17.04%
Day range:
$31.38 - $32.66
52-week range:
$25.53 - $40.28
Dividend yield:
0%
P/E ratio:
23.96x
P/S ratio:
2.68x
P/B ratio:
1.71x
Volume:
608.4K
Avg. volume:
767.2K
1-year change:
-5.49%
Market cap:
$1.8B
Revenue:
$661.8M
EPS (TTM):
$1.32

Supernus Pharmaceuticals SEC Filings

Company Filed Form Type Description
SUPN
Supernus Pharmaceuticals
05/08/2024 10-Q 10-Q filing on 05/08/2024 View Form
SUPN
Supernus Pharmaceuticals
11/08/2023 10-Q 10-Q filing on 11/08/2023 View Form
SUPN
Supernus Pharmaceuticals
08/08/2023 10-Q 10-Q filing on 08/08/2023 View Form
SUPN
Supernus Pharmaceuticals
05/09/2023 10-Q 10-Q filing on 05/09/2023 View Form
SUPN
Supernus Pharmaceuticals
11/09/2022 10-Q 10-Q filing on 11/09/2022 View Form
SUPN
Supernus Pharmaceuticals
08/08/2022 10-Q 10-Q filing on 08/08/2022 View Form
SUPN
Supernus Pharmaceuticals
05/12/2022 10-Q 10-Q filing on 05/12/2022 View Form
SUPN
Supernus Pharmaceuticals
11/05/2021 10-Q 10-Q filing on 11/05/2021 View Form
SUPN
Supernus Pharmaceuticals
08/06/2021 10-Q 10-Q filing on 08/06/2021 View Form
SUPN
Supernus Pharmaceuticals
05/07/2021 10-Q 10-Q filing on 05/07/2021 View Form
SUPN
Supernus Pharmaceuticals
11/06/2020 10-Q 10-Q filing on 11/06/2020 View Form
SUPN
Supernus Pharmaceuticals
08/17/2020 10-Q 10-Q filing on 08/17/2020 View Form
SUPN
Supernus Pharmaceuticals
05/15/2020 10-Q 10-Q filing on 05/15/2020 View Form
SUPN
Supernus Pharmaceuticals
02/28/2020 10-K 10-K filing on 02/28/2020 View Form
SUPN
Supernus Pharmaceuticals
11/08/2019 10-Q 10-Q filing on 11/08/2019 View Form
SUPN
Supernus Pharmaceuticals
08/09/2019 10-Q 10-Q filing on 08/09/2019 View Form
SUPN
Supernus Pharmaceuticals
05/10/2019 10-Q 10-Q filing on 05/10/2019 View Form
SUPN
Supernus Pharmaceuticals
03/01/2019 10-K 10-K filing on 03/01/2019 View Form
SUPN
Supernus Pharmaceuticals
11/09/2018 10-Q 10-Q filing on 11/09/2018 View Form
SUPN
Supernus Pharmaceuticals
08/09/2018 10-Q 10-Q filing on 08/09/2018 View Form
SUPN
Supernus Pharmaceuticals
05/10/2018 10-Q 10-Q filing on 05/10/2018 View Form
SUPN
Supernus Pharmaceuticals
03/01/2018 10-K 10-K filing on 03/01/2018 View Form
SUPN
Supernus Pharmaceuticals
11/09/2017 10-Q 10-Q filing on 11/09/2017 View Form
SUPN
Supernus Pharmaceuticals
08/03/2017 10-Q 10-Q filing on 08/03/2017 View Form
SUPN
Supernus Pharmaceuticals
05/09/2017 10-Q 10-Q filing on 05/09/2017 View Form
SUPN
Supernus Pharmaceuticals
03/16/2017 10-K 10-K filing on 03/16/2017 View Form
SUPN
Supernus Pharmaceuticals
01/23/2017 10-Q 10-Q filing on 01/23/2017 View Form
SUPN
Supernus Pharmaceuticals
01/20/2017 10-Q 10-Q filing on 01/20/2017 View Form
SUPN
Supernus Pharmaceuticals
01/20/2017 10-K 10-K filing on 01/20/2017 View Form
SUPN
Supernus Pharmaceuticals
08/05/2016 10-Q 10-Q filing on 08/05/2016 View Form
SUPN
Supernus Pharmaceuticals
05/10/2016 10-Q 10-Q filing on 05/10/2016 View Form
SUPN
Supernus Pharmaceuticals
03/09/2016 10-K 10-K filing on 03/09/2016 View Form
SUPN
Supernus Pharmaceuticals
11/09/2015 10-Q 10-Q filing on 11/09/2015 View Form
SUPN
Supernus Pharmaceuticals
08/07/2015 10-Q 10-Q filing on 08/07/2015 View Form
SUPN
Supernus Pharmaceuticals
05/06/2015 10-Q 10-Q filing on 05/06/2015 View Form

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will Nu Holdings Stock Be in 2030?
Where Will Nu Holdings Stock Be in 2030?

Despite fast growth, high profitability and an extraordinary runway ahead,…

Is it Too Late to Buy United Airlines Stock?
Is it Too Late to Buy United Airlines Stock?

United Airlines (NASDAQ:UAL) has thoroughly outpaced the broader stock market…

3 Smartest Dividend Stocks to Buy Now
3 Smartest Dividend Stocks to Buy Now

When the market entered a correction in February and March,…

Stock Ideas

Buy
56
Is AAPL Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 37x

Sell
46
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Sell
42
Is NVDA Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 37x

Alerts

Buy
100
DLICY alert for Apr 2

Dai-ichi Life Holdings [DLICY] is up 100.91% over the past day.

Buy
78
GATE alert for Apr 2

Marblegate Acquisition [GATE] is up 86.64% over the past day.

Sell
15
PCVX alert for Apr 2

Vaxcyte [PCVX] is down 14.62% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock